Crossmark

Evaluating the efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: a review of clinical trials versus real-world evidence

Crossref DOI link: https://doi.org/10.1007/s44337-025-00399-2

Published Online: 2025-06-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ogieuhi, Ikponmwosa Jude

Anthony, Chidera Stanley

Ajekiigbe, Victor Oluwatomiwa

Entonu, Alexander Idu

Agbo, Chinonyelum Emmanuel

Adegbesan, Christopher Abiodun

Okeke, Chukwuemelie Darlington

Oyetola, Emmanuel Oyedeji

Amusa, Oluwafemi

Ademoloye, Oluwafemi Ibukun

Ajimotokan, Oluwafemi Isaiah

Akinmeji, Olufemi

Terenik, Anna

Bakare, Ifeoluwa Sandra
License Information

Text and Data Mining valid from 2025-06-25

Version of Record valid from 2025-06-25
More Information

Article History

Received: 12 December 2024

Accepted: 19 June 2025

First Online: 25 June 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below